Funding sources This study was funded in part by a grant from Epiderm, Australia. Epiderm played no role in study design, data collection, data analysis, interpretation of data, manuscript preparation or publication decisions.
Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
Version of Record online: 5 OCT 2012
© 2012 The Authors. BJD © 2012 British Association of Dermatologists
British Journal of Dermatology
Volume 167, Issue 5, pages 1153–1160, November 2012
How to Cite
Anforth, R.M., Blumetti, T.C.M.P., Kefford, R.F., Sharma, R., Scolyer, R.A., Kossard, S., Long, G.V. and Fernandez-Peñas, P. (2012), Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma. British Journal of Dermatology, 167: 1153–1160. doi: 10.1111/j.1365-2133.2012.11155.x
Conflicts of interest The following conflicts of interest are declared: R.F.K. with GlaxoSmithKline and Roche; R.A.S. with GlaxoSmithKline, Roche and Abbott Molecular; G.V.L. with GlaxoSmithKline; and P.F.-P. with Roche.
- Issue online: 29 OCT 2012
- Version of Record online: 5 OCT 2012
- Accepted manuscript online: 16 JUL 2012 08:18PM EST
- Accepted for publication 11 July 2012
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.